BioHealth News Archive
WHO approves AstraZeneca/Oxford COVID-19 vaccine for emergency use | Reuters
GENEVA (Reuters) - The World Health Organization (WHO) on Monday listed AstraZeneca and Oxford University’s COVID-19 vaccine for emergency use, widening access to the…
Read More
Novavax Announces Expanded Collaboration and License Agreement with SK Bioscience for 40 Million Doses of COVID-19 Vaccine for South Korea
GAITHERSBURG, Md., Feb. 15, 2021 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, and SK…
Read More
AI Can Increase Efficiency in Healthcare, Even in a Pandemic | HealthTech Magazine
Artificial intelligence is often depicted in popular movies and TV dramas as technology that is determined to take over the world. Just a few…
Read MoreEnormous ancient fish discovered by accident | EurekAlert! Science News
Fossilised remains of a fish that grew as big as a great white shark and the largest of its type ever found have been…
Read More
How American universities can promote innovation: My long-read Q&A with Korok Ray | American Enterprise Institute – AEI
A key component of America’s ability to innovate is its world-renowned system of higher education, which is the envy of the world. owever, there’s room…
Read More
For mRNA vaccines, COVID-19 is just the beginning | Hub
Easy to manufacture and update, these new vaccines may be a powerful tool against emerging variants and other infectious diseases Even the experts were…
Read MoreRockville’s Sensei Biotherapeutics’ IPO hits $133M – Washington Business Journal
It's the latest in a series of public offerings for Greater Washington life sciences companies. Image: John Celebi is CEO of Sensei Biotherapeutics RICHARD…
Read More
BioHealth Innovation Adds Four NIH New Entrepreneurs-in-Residence
Renée JG Arnold, John Reinhart, Don Rose, and Kwame Ulmer join Diverse Entrepreneurs-in-Residence (EIR) Team ROCKVILLE, MARYLAND, February 8, 2021 – BioHealth Innovation…
Read More
University of Maryland Research Enterprise Ranked Among Top 10 Publics in NSF Higher Education R&D Survey | UMD Right Now :: University of Maryland
BALTIMORE and COLLEGE PARK, Md. – The University of Maryland achieved its highest ranking ever in the National Science Foundation’s (NSF) Higher Education Research…
Read More
Immunomic Therapeutics’ CEO to present at the BIO CEO & Investor Digital Conference – Bloomberg
Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today that the company will present at the BIO CEO & Investor Digital…
Read More
Exclusive: Johns Hopkins professor and biotech colleagues tout new tech to test Covid-19 vaccine response – Endpoints News
Vari ants to the SARS-CoV-2 virus have emerged of late as yet an oth er threat to a pan dem ic that’s al ready…
Read More
Salisbury Award Competition – Spring 2021
The Rockville-based National Foundation for Cancer Research is accepting applications through February 28 from academic laboratory and early stage start-up-based promising oncology technology projects…
Read MoreBaltimore venture capital investor Catalio Capital Management launches new funding option – Baltimore Business Journal
The new funding operation will be led by a pair of investment industry veterans who previously worked at Brown Advisory. Image: George Petrocheilos (right)…
Read More
GSK, CureVac to develop next-generation COVID-19 vaccines | Reuters
FRANKFURT, Feb 3 (Reuters) - Britain’s GlaxoSmithKline and German biotech firm CureVac struck a deal to develop next-generation vaccines against COVID-19 that target several…
Read More
5 People in the BioHealth Capital Region You Should Know In 2021 – BioBuzz
2020 brought about a lot of growth across the BioHealth Capital Region (BHCR) as dozens of organizations responded with urgency to address the COVID-19…
Read More